Entrada Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023- Entrada Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 04, 2023
- Entrada Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
Entrada Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Welcome to the conference. My name is Chris Shibutani, I'm a member of the research effort. All the hard work gets done by Stephen Sloan, who's joining me up stage here. Entrada, ticker TRDA, we've known you guys for a couple of years. We're really pleased to have you join us once again, Dipal Doshi, President and CEO; and Natarajan Sethuraman, Chief Scientific Officer. So the business powerhouse through scientific trust.
Entrada, even the name of the company has a meaning in terms of foundationally what you guys do. And we're going to get into the details, and Stephen Sloan will ask all the relevant precise questions that think about the model and your pipeline, et cetera.
Questions & Answers
It's almost [majority] say that you're like a drug delivery company. But within that, there is just really a platform and there are strategic decisions that you've made about sort of like
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
